
CME Group (CME) Stock Forecast & Price Target
CME Group (CME) Analyst Ratings
Bulls say
CME Group has reported a total revenue of $1,649 million for the recent quarter, reflecting a year-over-year increase of approximately 8.1%, with significant contributions from its Market Data segment, which grew by around 14.5% due to new users and pricing strategies. The firm has demonstrated a strong history of free cash flow generation, enabling it to consistently raise its dividend payments for over 14 years, underscoring its financial stability and commitment to returning value to shareholders. Additionally, the company's robust average daily volume (ADV) growth, which has a compound annual growth rate of over 7% from FY16 through FY24, combined with planned revenue enhancements from market data fees, positions CME favorably for continued financial performance and value creation in the future.
Bears say
CME Group faces significant challenges that contribute to a negative financial outlook, primarily characterized by anticipated declines in interest rate futures trading volume due to an ongoing rate-cutting cycle. The company's projected revenue growth of approximately 5.4% year-over-year falls below the consensus estimate of 6.0%, indicating potential underperformance in achieving financial targets. Additionally, regulatory risks, increased competition, and changing industry fundamentals could adversely impact trading volumes and pricing, further compounding concerns regarding the stock's future performance.
This aggregate rating is based on analysts' research of CME Group and is not a guaranteed prediction by Public.com or investment advice.
CME Group (CME) Analyst Forecast & Price Prediction
Start investing in CME Group (CME)
Order type
Buy in
Order amount
Est. shares
0 shares